This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
About
Dr Sloan Wang
Research Fellow, Retinal Gene Therapy
Dr Sloan Wang is a Postdoctoral Research Fellow with a focus on molecular biology and gene therapy.
Dr Sloan Wang
Research Fellow, Retinal Gene Therapy
PhD
Dr Sloan Wang is a Research Fellow in CERA’s Retinal Gene Therapy team, working on a preclinical study of a gene therapy for an inherited ocular disease.
He received his PhD in Ophthalmology from the University of Melbourne in 2018, investigating the role of microRNAs (molecules that regulate gene expression) in retinal neovascularisation, a severe complication of diabetic eye disease.
Through his recent travels to the leading gene therapy groups in Oxford and MD Anderson Cancer Centre, Dr Wang has gained skills in applying a powerful gene editing tool, CRISPR, to tune gene expression in vitro and in vivo, and strategies to develop novel AAV serotypes.
Contact Dr Sloan Wang
Leave a direct enquiry for CERA below!
Please note: Unfortunately we are not able to provide individual medical advice over email.
